Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 49,164 | 48,462 | 39,188 | 22,780 | 37,799 |
| Cost of Goods | 32,440 | 32,551 | 22,659 | 16,607 | 23,511 |
| Gross Profit | 16,724 | 15,911 | 16,529 | 6,173 | 14,288 |
| Operating Expenses | 35,101 | 41,800 | 33,619 | 25,316 | 30,420 |
| Operating Income | -17,937 | -25,338 | -16,431 | -18,536 | -15,621 |
| Interest Expense | 2,361 | 2,749 | 2,224 | 2,359 | 2,157 |
| Other Income | -303 | -438 | 2,562 | 4,194 | -121 |
| Pre-tax Income | -20,601 | -28,525 | -16,093 | -16,701 | -17,899 |
| Income Tax | 31 | 109 | 65 | 128 | -44 |
| Net Income Continuous | -20,632 | -28,634 | -16,158 | -16,829 | -17,855 |
| Net Income | $-20,632 | $-28,634 | $-16,158 | $-16,829 | $-17,855 |
| EPS Basic Total Ops | -29.44 | -418.13 | -283.12 | -1,399.00 | -1,925.00 |
| EPS Basic Continuous Ops | -16.14 | -414.99 | -273.86 | -688.30 | -1,923.95 |
| EPS Diluted Total Ops | -29.44 | -418.13 | -283.12 | -1,399.00 | -1,925.00 |
| EPS Diluted Continuous Ops | -16.14 | -414.99 | -273.86 | -688.30 | -1,923.95 |
| EPS Diluted Before Non-Recurring Items | -29.44 | -416.00 | -325.00 | -1,400.00 | -1,925.00 |
| EBITDA(a) | $-14,713 | $-23,645 | $-15,516 | $-17,541 | $-14,311 |